메뉴 건너뛰기




Volumn 37, Issue 1, 2011, Pages 78-84

Diabetes oral medication initiation and intensification: Patient views compared with current treatment guidelines

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

EID: 79952060302     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721710388427     Document Type: Article
Times cited : (47)

References (29)
  • 1
    • 9444244406 scopus 로고    scopus 로고
    • Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S
    • Gregg EW, Cadwell BL, Cheng YJ,et al.Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S Diabetes Care. 2004;27:2806-2812.
    • (2004) Diabetes Care , vol.27 , pp. 2806-2812
    • Gregg, E.W.1    Cadwell, B.L.2    Cheng, Y.J.3
  • 2
    • 61849170118 scopus 로고    scopus 로고
    • Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006
    • Cowie CC, Rust KF, Ford ES,et al.Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287-294.
    • (2009) Diabetes Care , vol.32 , pp. 287-294
    • Cowie, C.C.1    Rust, K.F.2    Ford, E.S.3
  • 3
    • 65349187027 scopus 로고    scopus 로고
    • Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage
    • McWilliams JM, Meara E., Zaslavsky AM, Ayanian JZ Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med. 2009;150:505-515.
    • (2009) Ann Intern Med. , vol.150 , pp. 505-515
    • McWilliams, J.M.1    Meara, E.2    Zaslavsky, A.M.3    Ayanian, J.Z.4
  • 4
    • 0347133334 scopus 로고    scopus 로고
    • Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    • Saydah SH, Fradkin J., Cowie CC Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
    • (2004) JAMA , vol.291 , pp. 335-342
    • Saydah, S.H.1    Fradkin, J.2    Cowie, C.C.3
  • 5
    • 38949210220 scopus 로고    scopus 로고
    • Effect of a multifactorial intervention on mortality in type 2 diabetes
    • Gaede P., Lund-Andersen H., Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.
    • (2008) N Engl J Med , vol.358 , pp. 580-591
    • Gaede, P.1    Lund-Andersen, H.2    Parving, H.H.3    Pedersen, O.4
  • 6
    • 12844281026 scopus 로고    scopus 로고
    • Quality of diabetes care in US academic medical centers: low rates of medical regimen change
    • Grant RW, Buse JB, Meigs JB Quality of diabetes care in US academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442.
    • (2005) Diabetes Care , vol.28 , pp. 337-442
    • Grant, R.W.1    Buse, J.B.2    Meigs, J.B.3
  • 7
    • 66549085346 scopus 로고    scopus 로고
    • Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD)
    • McEwen LN, Bilik D., Johnson SL,et al.Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care. 2009;32:971-976.
    • (2009) Diabetes Care , vol.32 , pp. 971-976
    • McEwen, L.N.1    Bilik, D.2    Johnson, S.L.3
  • 8
    • 33744472168 scopus 로고    scopus 로고
    • Unintended consequences of caps on Medicare drug benefits
    • Hsu J., Price M., Huang J.,et al.Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354:2349-2359.
    • (2006) N Engl J Med , vol.354 , pp. 2349-2359
    • Hsu, J.1    Price, M.2    Huang, J.3
  • 9
    • 34250029391 scopus 로고    scopus 로고
    • Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin
    • Parchman ML, Pugh JA, Romero RL, Bowers KW Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5:196-201.
    • (2007) Ann Fam Med , vol.5 , pp. 196-201
    • Parchman, M.L.1    Pugh, J.A.2    Romero, R.L.3    Bowers, K.W.4
  • 10
    • 34147109354 scopus 로고    scopus 로고
    • Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management
    • Grant RW, Adams AS, Trinacty CM,et al.Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30: 807-812.
    • (2007) Diabetes Care , vol.30 , pp. 807-812
    • Grant, R.W.1    Adams, A.S.2    Trinacty, C.M.3
  • 11
    • 33746588255 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB,et al.Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006;29:1963-1972.
    • (2006) Diabetes Care , vol.29 , pp. 1963-1972
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 12
    • 60449089649 scopus 로고    scopus 로고
    • Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB,et al.Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 14
    • 9444241529 scopus 로고    scopus 로고
    • Clinical outcomes and adherence to medications measured by claims data in patients with diabetes
    • Pladevall M., Williams LK, Potts LA, Divine G., Xi H., Lafata JE Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27: 2800-2805.
    • (2004) Diabetes Care , vol.27 , pp. 2800-2805
    • Pladevall, M.1    Williams, L.K.2    Potts, L.A.3    Divine, G.4    Xi, H.5    Lafata, J.E.6
  • 15
    • 0036596681 scopus 로고    scopus 로고
    • The association between diabetes metabolic control and drug adherence in an indigent population
    • Schectman JM, Nadkarni MM, Voss JD The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021.
    • (2002) Diabetes Care , vol.25 , pp. 1015-1021
    • Schectman, J.M.1    Nadkarni, M.M.2    Voss, J.D.3
  • 16
    • 61849125856 scopus 로고    scopus 로고
    • Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes
    • Huang ES, Brown SE, Thakur N.,et al.Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009;32:311-316.
    • (2009) Diabetes Care , vol.32 , pp. 311-316
    • Huang, E.S.1    Brown, S.E.2    Thakur, N.3
  • 17
    • 64549094715 scopus 로고    scopus 로고
    • Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments
    • Aikens JE, Piett JD Diabetic patients' medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009;32:19-24.
    • (2009) Diabetes Care , vol.32 , pp. 19-24
    • Aikens, J.E.1    Piett, J.D.2
  • 18
    • 33744521154 scopus 로고    scopus 로고
    • Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance
    • Hayes RP, Bowman L., Monahan PO, Marrero DG, McHorney CA Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance. Diabetes Educ. 2006;32:404-414.
    • (2006) Diabetes Educ , vol.32 , pp. 404-414
    • Hayes, R.P.1    Bowman, L.2    Monahan, P.O.3    Marrero, D.G.4    McHorney, C.A.5
  • 21
    • 0032739376 scopus 로고    scopus 로고
    • How will we know good qualitative research when we see it? Beginning the dialogue in health services research
    • Devers KJ How will we know good qualitative research when we see it? Beginning the dialogue in health services research. Health Serv Res. 1999;34:1153-1188.
    • (1999) Health Serv Res , vol.34 , pp. 1153-1188
    • Devers, K.J.1
  • 22
    • 33644798145 scopus 로고    scopus 로고
    • Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
    • Peyrot M., Rubin RR, Lauritzen T.,et al.Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28:2673-2679.
    • (2005) Diabetes Care , vol.28 , pp. 2673-2679
    • Peyrot, M.1    Rubin, R.R.2    Lauritzen, T.3
  • 23
    • 0031018185 scopus 로고    scopus 로고
    • NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance
    • Hunt LM, Valenzuela MA, Pugh JA NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20:292-298.
    • (1997) Diabetes Care , vol.20 , pp. 292-298
    • Hunt, L.M.1    Valenzuela, M.A.2    Pugh, J.A.3
  • 25
    • 25644457629 scopus 로고    scopus 로고
    • Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem
    • Polonsky WH, Fisher L., Guzman S., Villa-Caballero L., Edelman SV Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28:2543-2545.
    • (2005) Diabetes Care , vol.28 , pp. 2543-2545
    • Polonsky, W.H.1    Fisher, L.2    Guzman, S.3    Villa-Caballero, L.4    Edelman, S.V.5
  • 26
    • 48049090498 scopus 로고    scopus 로고
    • Measuring psychological insulin resistance: barriers to insulin use
    • Larkin ME, Capasso VA, Chen CL,et al.Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ. 2008;34:511-517.
    • (2008) Diabetes Educ , vol.34 , pp. 511-517
    • Larkin, M.E.1    Capasso, V.A.2    Chen, C.L.3
  • 27
    • 65349135281 scopus 로고    scopus 로고
    • National standards for diabetes self-management education
    • Funnell MM, Brown TL, Childs BP,et al.National standards for diabetes self-management education. Diabetes Care. 2009;32: S87-S94.
    • (2009) Diabetes Care. , vol.32
    • Funnell, M.M.1    Brown, T.L.2    Childs, B.P.3
  • 28
    • 70350140343 scopus 로고    scopus 로고
    • In the beginning: setting the stage for effective diabetes care
    • Weiss MA, Funnell MM In the beginning: setting the stage for effective diabetes care. Clin Diabetes. 2009;27:149-151.
    • (2009) Clin Diabetes , vol.27 , pp. 149-151
    • Weiss, M.A.1    Funnell, M.M.2
  • 29
    • 77953360245 scopus 로고    scopus 로고
    • Patient empowerment: myths and misconceptions
    • Anderson RM, Funnell MM Patient empowerment: myths and misconceptions. Patient Educ Couns. 2010;79:277-282.
    • (2010) Patient Educ Couns , vol.79 , pp. 277-282
    • Anderson, R.M.1    Funnell, M.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.